Toxoplasmosis in Cats: Risks During Pregnancy and Prevention

Introduction

Toxoplasmosis is a globally distributed zoonotic disease caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii [1, 2]. The parasite can infect all warm-blooded animals, including birds and mammals, and it is estimated that approximately 30% of the human population carries the parasite [3]. Felids, both domestic and wild, serve as the definitive hosts for T. gondii because they are the only species capable of excreting environmentally resistant oocysts in their feces [1, 3]. This unique biological role places cats at the center of the parasite's epidemiology and makes them a critical focus for public health interventions, particularly concerning the risks to pregnant women [4, 5]. The relationship between feline infection and human disease, especially the concern for congenital transmission, is often summarized under the search term 'cat toxoplasmosis baby', reflecting a primary public health anxiety. This article provides a detailed veterinary and molecular review of toxoplasmosis in cats, the mechanisms of zoonotic transmission, the specific risks during pregnancy, and evidence-based prevention strategies.

Etiology and Life Cycle of Toxoplasma gondii

Toxoplasma gondii exists in three principal infectious stages: tachyzoites (rapidly dividing form), bradyzoites (slowly dividing form within tissue cysts), and sporozoites (within oocysts) [1, 6]. The definitive host, the cat, becomes infected by ingesting any of these stages, most commonly through predation on intermediate hosts (e.g., rodents, birds) containing tissue cysts with bradyzoites [1, 33]. Following ingestion, the bradyzoites are released in the feline small intestine, where they invade enterocytes and initiate a complex enteroepithelial cycle [6, 33]. This cycle culminates in the production of unsporulated (non-infectious) oocysts, which are shed in the feces [1, 6]. The prepatent period, the time from infection to the onset of oocyst shedding, varies depending on the stage ingested. It is typically 3 to 10 days after ingestion of bradyzoites (tissue cysts) but can be 18 days or longer after ingestion of tachyzoites or oocysts [6, 7]. A cat can excrete millions of oocysts over a period of 1 to 3 weeks, and a single cat can contaminate a wide area, spreading infection to many hosts [1, 3].

Once shed into the environment, oocysts undergo sporulation, becoming infectious. Sporulation occurs within 1 to 5 days under favorable conditions of warmth and aeration [1]. Sporulated oocysts are extremely resilient and can remain infectious in soil, water, and on surfaces for months to years [1, 31]. Intermediate hosts, including humans, become infected primarily through the accidental ingestion of sporulated oocysts from contaminated environments (e.g., soil, cat litter, unwashed produce) or through the consumption of undercooked meat containing tissue cysts [3, 8].

Prevalence and Epidemiology in Feline Populations

The seroprevalence of T. gondii in cats varies widely depending on geographic location, lifestyle (owned vs. stray), age, and diagnostic methods used [9, 10, 34]. Studies have reported seroprevalence rates ranging from 6% to over 70% in different populations [11, 10, 5]. For example, a study in Kırıkkale, Turkey, using rapid immunochromatographic kits, found a prevalence of 6% in a hospital population of 50 cats [11]. In contrast, a study in Pakistan reported a significantly higher infection rate of 74.6% in stray cats compared to 25.4% in pet cats [10]. Similarly, research in Bangkok, Thailand, found a prevalence of 11.5% in semi-domesticated cats versus 1.5% in owned pet cats, with semi-domesticated cats having 8.34 times higher odds of infection [9]. A study in Greece reported a seroprevalence of 20.8% in 457 cats, identifying older age, a history of cat-fight trauma, and lack of routine vaccination as significant risk factors [34]. In Slovakia, a seroprevalence of 37.4% was found in a mixed population of owned and shelter cats [4]. These data underscore that free-roaming and stray cats, which have greater exposure to infected prey, represent a higher risk for environmental contamination with oocysts [9, 10, 5].

Clinical Toxoplasmosis in Cats

While seroprevalence is high, clinical toxoplasmosis in cats is relatively rare [12, 2, 33]. Most infected cats remain asymptomatic, but disease can manifest, particularly in young kittens or immunocompromised individuals [12, 13, 33]. A retrospective study of 100 histologically confirmed cases found that clinical signs were most frequently associated with the pulmonary, abdominal, and neurologic systems [12]. Common clinical signs include fever, dyspnea, polypnea, anorexia, lethargy, and abdominal discomfort [12, 14]. Neurological and ocular forms are also well-documented, with ocular lesions such as multifocal iridocyclochoroiditis being common [15, 12, 16]. In a study of 100 cats with clinical toxoplasmosis, 81.5% of the 27 cats examined had evidence of intraocular inflammation [12]. Neonatal toxoplasmosis, acquired transplacentally or postnatally, can result in severe, often fatal, disseminated disease in kittens [13, 33]. Fatal acute toxoplasmosis has been reported in littermate kittens, associated with the ToxoDB genotype #4, which is commonly found in wildlife [33].

Zoonotic Transmission and Risks During Pregnancy

The primary public health concern regarding feline toxoplasmosis is the risk of zoonotic transmission to humans, particularly to pregnant women and immunocompromised individuals [1, 4, 2]. Humans can acquire T. gondii infection through three main routes: (1) ingestion of sporulated oocysts from the environment, (2) ingestion of tissue cysts in undercooked or raw meat, and (3) congenital transmission from mother to fetus [3, 8]. The role of cats in human infection is primarily through the dissemination of oocysts into the environment [1, 3, 5]. Stray cats, in particular, have been identified as a significant source of environmental contamination. A study in Izmir, Turkey, detected T. gondii DNA in the feces of 14.37% of stray cats, highlighting their potential role in transmission [5]. Another study in Pakistan found that stray cats had a significantly higher infection rate (74.6%) than pet cats [10].

The risk of a pregnant woman acquiring toxoplasmosis from her pet cat is often overstated but is a legitimate concern that requires evidence-based management. The greatest risk is from the accidental ingestion of sporulated oocysts. This can occur through direct contact with cat feces (e.g., cleaning the litter box) or indirect contact with contaminated soil, gardening without gloves, or consuming unwashed fruits and vegetables [3, 31]. The term 'cat toxoplasmosis baby' encapsulates the fear of congenital toxoplasmosis, which can occur when a woman acquires a primary T. gondii infection during pregnancy [8]. Congenital infection can lead to severe outcomes for the fetus, including chorioretinitis, intracranial calcifications, hydrocephalus, and developmental delays [2, 8]. The risk of fetal infection and the severity of disease depend on the trimester in which maternal infection occurs, with first-trimester infections being less common but more severe [2].

Diagnosis of Toxoplasmosis in Cats

Accurate diagnosis of T. gondii infection in cats is essential for both clinical management and epidemiological surveillance. A variety of serological and molecular methods are available [11, 1, 17].

Serological Methods

Serological detection of anti-T. gondii antibodies (IgG and IgM) is the most common diagnostic approach [11, 1, 17]. Several tests are available, including the modified agglutination test (MAT), indirect fluorescent antibody test (IFAT), enzyme-linked immunosorbent assay (ELISA), and Sabin-Feldman dye test [11, 18, 17]. The MAT using formalin-preserved tachyzoites is considered highly sensitive for detecting chronic infections [18]. Commercial ELISA kits are widely used for their convenience and ability to differentiate between IgG and IgM, which can help distinguish between chronic and recent or reactivated infections [10, 17]. A study comparing recombinant antigens SAG2, GRA6, and GRA7 for serodiagnosis in cats found that GRA7 was the most sensitive antigen [17]. Rapid immunochromatographic test kits are also used in clinical settings due to their ease of use, cost-effectiveness, and rapid results, though they may have lower sensitivity compared to laboratory-based methods [11].

Molecular Methods

Polymerase chain reaction (PCR) is a highly sensitive and specific method for detecting T. gondii DNA in various clinical samples, including blood, feces, and tissues [11, 10, 5]. Real-time PCR assays are particularly useful for quantifying parasite burden and detecting DNA in fecal samples, which is critical for identifying actively shedding cats [5]. A study in Pakistan used PCR to detect T. gondii DNA in cats, finding a significant correlation with seropositivity [10]. Molecular methods are also essential for genotyping T. gondii strains, which can have implications for virulence and epidemiology [1, 33].

Fecal Examination

Microscopic examination of feces for oocysts is a direct method of diagnosis, but it has low sensitivity because oocyst shedding is intermittent and of short duration [1, 5]. Flotation techniques can concentrate oocysts, but they are often indistinguishable from other coccidian oocysts without molecular confirmation [5, 31]. A study in Sidoarjo, Indonesia, used the floating method to detect T. gondii oocysts in stray cats, with prevalence rates ranging from 12.5% to 37.5% depending on the market location [31].

Treatment of Feline Toxoplasmosis

Treatment is indicated for cats with clinical toxoplasmosis [2, 19]. The standard therapeutic approach involves the use of antibiotics that inhibit the replication of tachyzoites. Clindamycin is the most commonly recommended drug for treating clinical toxoplasmosis in cats [20, 2, 32]. It is administered orally or parenterally at a dosage of 10-12 mg/kg every 12 hours for 2-4 weeks [2]. However, a paradoxical effect has been observed in experimental acute toxoplasmosis, where clindamycin treatment led to increased oocyst shedding in some cats [20]. Other drugs used include trimethoprim-sulfonamide combinations and pyrimethamine, though these are less commonly used in cats due to potential adverse effects [2, 19]. In zoo settings, clindamycin has been used prophylactically to reduce juvenile toxoplasmosis-associated mortality in Pallas' cats, resulting in a 67% reduction in first-year mortality [32]. A live attenuated vaccine (RHΔompdcΔuprt) has shown promise in experimental settings, inducing strong protective immunity and reducing oocyst shedding by 95.3% in vaccinated cats, but it is not yet commercially available [21].

Prevention Strategies

Prevention of toxoplasmosis in both cats and humans requires a multi-faceted approach focusing on reducing environmental contamination and minimizing exposure to oocysts [1, 19, 34].

Prevention in Cats

1. Dietary Management: Feed cats only commercially processed, cooked, or canned food. Do not feed raw or undercooked meat, as this is a primary source of T. gondii tissue cysts [1, 33].
2. Indoor Confinement: Keep cats indoors to prevent them from hunting and ingesting infected intermediate hosts (e.g., rodents, birds) [1, 9, 34].
3. Litter Box Hygiene: Clean litter boxes daily, as oocysts require 1-5 days to sporulate and become infectious [1]. Use gloves and wash hands thoroughly after cleaning. Disinfect litter boxes with boiling water or a 10% ammonia solution to kill oocysts [1].
4. Population Control: Implement spay/neuter programs to reduce the population of free-roaming and stray cats, which are a major source of environmental contamination [9, 10, 5].

Prevention in Humans (Especially During Pregnancy)

1. Avoid Contact with Cat Feces: Pregnant women and immunocompromised individuals should avoid cleaning the litter box. If this is unavoidable, they should wear disposable gloves and wash hands immediately afterward [1, 19].
2. Hand Hygiene: Wash hands thoroughly with soap and water after any contact with cats, soil, or raw meat [1, 3].
3. Food Safety: Cook meat to a safe internal temperature (at least 67°C for whole cuts and 74°C for ground meat) to kill tissue cysts [1, 3]. Wash all fruits and vegetables thoroughly before consumption.
4. Gardening Precautions: Wear gloves when gardening, as soil may be contaminated with oocysts from cat feces [3, 31].
5. Cover Sandboxes: Keep children's sandboxes covered when not in use to prevent cats from defecating in them [1].

The following decision tree summarizes the key steps in managing the risk of toxoplasmosis in a household with a pregnant woman and a cat.

graph TD
    A[Pregnant Woman Lives with Cat], > B{Is the cat strictly indoor?};
    B, Yes, > C[Low Risk: Cat unlikely to be infected];
    B, No, > D[Higher Risk: Cat may hunt and eat prey];
    C, > E[Continue standard prevention: daily litter box cleaning by another person, feed only cooked/commercial food];
    D, > F[Implement strict prevention: convert cat to indoor lifestyle, test cat for T. gondii seropositivity];
    F, > G{Is the cat seropositive?};
    G, Yes, > H[Cat has been exposed. Risk of oocyst shedding is low unless recent infection. Maintain hygiene];
    G, No, > I[Cat is susceptible. Strictly prevent hunting and raw feeding to avoid primary infection during pregnancy];
    E, > J[Risk of congenital toxoplasmosis minimized];
    H, > J;
    I, > J;

Conclusion

Toxoplasmosis in cats remains a significant zoonotic concern, particularly due to the risk of congenital infection in humans. Cats are the only definitive hosts capable of shedding the environmentally robust oocysts of T. gondii [1, 3]. While the prevalence of infection in feline populations is high globally, the risk of transmission from a well-managed, indoor pet cat to a pregnant owner is low and can be effectively mitigated through simple hygiene and management practices [1, 9, 19]. Stray and free-roaming cats pose a greater public health risk due to their higher infection rates and role in environmental contamination [9, 10, 5]. Veterinary professionals play a crucial role in educating clients about the biology of T. gondii, the importance of preventive measures, and the appropriate diagnostic and therapeutic approaches for feline toxoplasmosis. Continued research into vaccine development and improved diagnostic tools will further enhance the control of this important parasite [21, 17].

References

[1] Dubey, J., Cerqueira-Cézar, C. K., Murata, F., et al. (2020). All about toxoplasmosis in cats: the last decade. Veterinary Parasitology. Link

[2] Calero-Bernal, R., & Gennari, S. (2019). Clinical Toxoplasmosis in Dogs and Cats: An Update. Frontiers in Veterinary Science. Link

[3] Fux, B., Covre, K., Lopes, R., et al. (2020). Seroprevalence of Toxoplasmosis in Cats in Espirito Santo State, Brazil. Current Developments in Nutrition. Link

[4] Selyemová, D., Antolová, D., Mangová, B., et al. (2024). Cats as a sentinel species for human infectious diseases – toxoplasmosis, trichinellosis, and COVID-19. Current Research in Parasitology and Vector-Borne Diseases. Link

[5] Karakavuk, M., Can, H., Selim, N., et al. (2021). Investigation of the role of stray cats for transmission of toxoplasmosis to humans and animals living in İzmir, Turkey. Journal of Infection in Developing Countries. Link

[6] Dubey, J., & Frenkel, J. K. (1972). Cyst-induced toxoplasmosis in cats. The Journal of Protozoology. Link

[7] Dubey, J. (1986). Toxoplasmosis in cats. Journal. Link

[8] Hasan, M. F., Harun, A., Hossain, D., et al. (2024). Toxoplasmosis in animals and humans: a neglected zoonotic disease in Bangladesh. Journal of Parasitic Diseases. Link

[9] Inpankaew, T., Sattasathuchana, P., Kengradomkij, C., et al. (2021). Prevalence of toxoplasmosis in semi-domesticated and pet cats within and around Bangkok, Thailand. BMC Veterinary Research. Link

[10] Majid, A., Ahmad, N., Haleem, S., et al. (2021). Detection of toxoplasmosis in pets and stray cats through molecular and serological techniques in Khyber Pakhtunkhwa, Pakistan. BMC Veterinary Research. Link

[11] Parlatır, Y., Şenel, Y., & Kara, E. (2025). Determination of the Prevalance of Toxoplasmosis in Cats with Immunochoromatographic Rapid Tests Kits in Kırıkkale University Veterinary Faculty Animal Hospital. Research and Practice in Veterinary and Animal Science. Link

[12] Dubey, J., & Carpenter, J. (1993). Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association. Link

[13] Dubey, J., Mattix, M., & Lipscomb, T. (1996). Lesions of Neonatally Induced Toxoplasmosis in Cats. Veterinary Pathology-Supplement. Link

[14] Bastan, I. (2018). Clinical and some laboratory findings in cats with Toxoplasmosis. Journal. Link

[15] Cucoș, C., Ionașcu, I., Mocanu, J., et al. (2015). Neurological and ocular form of toxoplasmosis in cats. Journal. Link

[16] Vainisi, S. J., & Campbell, L. H. (1969). Ocular toxoplasmosis in cats. Journal. Link

[17] Sabukunze, S., Gu

[18] Dubey, J., & Thulliez, P. (1989). Serologic diagnosis of toxoplasmosis in cats fed Toxoplasma gondii tissue cysts. Journal of the American Veterinary Medical Association. Link

[19] Frenkel, J. K. (1978). Toxoplasmosis in cats: diagnosis, treatment and prevention. Comparative Immunology, Microbiology & Infectious Diseases. Link

[20] Davidson, M. G., Lappin, M., Rottman, J. R., et al. (1996). Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats. Antimicrobial Agents and Chemotherapy. Link

[21] Shen, Y., Zheng, B., Sun, H., et al. (2023). A live attenuated RHΔompdcΔuprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats. Infectious Diseases of Poverty. Link

[22] Munhoz, A., Hage, S. B., Cruz, R., et al. (2017). Toxoplasmosis in cats in northeastern Brazil: Frequency, associated factors and coinfection with Neospora caninum, feline immunodeficiency virus and feline leukemia virus. Veterinary Parasitology: Regional Studies and Reports. Link

[23] Ahmad, N., Ahmed, H., Irum, S., et al. (2014). Seroprevalence of IgG and IgM antibodies and associated risk factors for toxoplasmosis in cats and dogs from sub-tropical arid parts of Pakistan. Tropical Biomedicine. Link

[24] Al-kappany, Y., Rajendran, C., Ferreira, L. R., et al. (2010). High Prevalence of Toxoplasmosis in Cats from Egypt: Isolation of Viable Toxoplasma gondii, Tissue Distribution, and Isolate Designation. Journal of Parasitology. Link

[25] Shahzad, A., Khan, M. S., Ashraf, K., et al. (2006). Sero-epidemiological and haematological studies on toxoplasmosis in cats, dogs and their owners in Lahore, Pakistan. Journal. Link

[26] Dubey, J. P., Hoover, E., & Walls, K. (1977). Effect of age and sex on the acquisition of immunity to toxoplasmosis in cats. The Journal of Protozoology. Link

[27] Zafar, Z., Ali, N., & Baleanu, D. (2021). Dynamics and numerical investigations of a fractional-order model of toxoplasmosis in the population of human and cats. Journal. Link

[28] Germano, P. M., Melo, H., Bianchin, I., et al. (1980). Toxoplasmosis in cats and dogs. Journal. Link

[29] Vinogradov, L. I. (1980). Diagnosis of toxoplasmosis in cats. Journal. Link

[30] Dubey, J. P., Lehmann, T., Lautner, F., et al. (2015). Toxoplasmosis in sentinel chickens (Gallus domesticus) in New England farms: Seroconversion, distribution of tissue cysts in brain, heart, and skeletal muscle by bioassay in mice and cats. Veterinary Parasitology. Link